ISCT Open Access Webinars

Back to Resource Library

Unproven Stem Cell Treatments: Law & Ethics 

Nov 02, 2023 16:03


Unproven Stem Cell Treatments: Law & Ethics

Presented by the ANZ Legal & Regulatory Affairs (ANZ LRA) Committee  & The Committee on the Ethics of Cell and Gene Therapy (ECGT)  

 

Although there are private stem cell clinics that promote the use of stem cells to treat several illnesses and conditions worldwide, only a few have established procedures. 

An ever-growing industry targets vulnerable patients all over the world. While stem cells might offer the potential to treat diseases or conditions, there have been accounts of claims of miracle cures and adverse events, including deaths. 

Thus, there is a need to examine these ethical violations and the relevant legal issues. These critical matters will be explored in this webinar.

Chair:

Patrick Foong, PhD

Senior Lecturer

Western Sydney University

Australia 








Speakers:

Douglas Sipp, BA

Researcher

RIKEN Center for Biosystems Dynamics Research

Japan

 

A Brief History of Stem Cell Mismarketing

Douglas Sipp is a researcher at the Riken Center for Biosystems Dynamics Research. Doug's research focus is on international policy, law, and economics issues relating to stem cells and regenerative medicine. His chief interests are in direct-to-consumer marketing of unproven stem cell interventions, and de-regulatory pressures in the context of national stem cell R&D initiatives.

Megan Munsie, PhD

Professor

University of Melbourne

Australia 

 

Unproven Stem Cell Treatments in Australia: TGA Regulations

Megan Munsie is a Professor in the Department of Medicine at the University of Melbourne and a Group Leader at the Murdoch Children’s Research Institute.  Her research focuses on the development of policy and professional standards to enable responsible translation of stem cell and related research and understanding community views about this and other areas of biotechnology. Findings from her research have influenced policy reforms at a national and international level and informed the design and delivery of educational resources for patients, healthcare professionals, and the general public.

Leigh Turner, PhD

Professor

University of California Irvine

USA

 

Unproven Stem Cell Treatments in US: Regulatory Challenges

Leigh Turner is a Professor in the Department of Health, Society, & Behavior at the University of California, Irvine. He is also a member of UCI’s Stem Cell Research Center.  Turner’s current research addresses ethical, legal, and social issues related to stem cells and regenerative medicine. products. In particular, his research examines the commercial practices of businesses engaged in direct-to-consumer marketing of unproven and unlicensed cell-based interventions. 





#Webinar
#ISCT
#ANZ
#Regulatory

Statistics
15 Views
1 Files
0 Shares
1 Downloads

Related Entries and Links

No Related Resource entered.